Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
health policy poliomyelitis Recommendation Indonesia Haemophilus influenzae type B Diphtheria Hepatitis B Tetanus Poliomyelitis Pertussis
Download:
health policy Recommendation Indonesia Haemophilus influenzae type B Diphtheria Hepatitis B Tetanus Pertussis
Download:
health policy poliomyelitis France Diphtheria Tetanus Poliomyelitis Pertussis
Download:
health policy Recommendation Germany Meningitis Measles Rubella
Download: